Incyte
| Company type | Public |
|---|---|
| Industry | pharmaceuticals |
| Founded | 2002 |
| Headquarters | Wilmington, Delaware, U.S. |
Key people | Hervé Hoppenot (CEO, chairman & president) |
| Revenue | US$4.24 billion (2024) |
| US$61.4 million (2024) | |
| US$32.6 million (2024) | |
| Total assets | US$5.44 billion (2024) |
| Total equity | US$3.45 billion (2024) |
Number of employees | 2,617 (2024) |
| Website | incyte |
| Footnotes / references | |
Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware. The company currently operates manufacturing and R&D locations in North America, Europe, and Asia.
Incyte Corporation currently develops and manufactures prescription biopharmaceutical medications in multiple therapeutic areas including oncology, inflammation, and autoimmunity.